GL1X · GenesisL1 explorer

Research workbench

Vaccine-elicited NHP FP-targeting neutralizing antibody DF2F-b.04 in complex with HIV fusion peptide (residue 512-519)

Analyse Vaccine-elicited NHP FP-targeting neutralizing antibody DF2F-b.04 in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6P7H
Type
protein
Length
437 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.782
Source
Platyrrhini; SYNTHETIC CONSTRUCT
Molecule
Antibody DF2F-b.04 light chain; Antibody DF2F-b.04 heavy chain; HIV fusion peptide…
Pockets
2 · best druggability 0.58

Structure

x-ray diffraction · resolution 1.782 · 3 distinct chains · 6% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BAntibody DF2F-b.04 light chainprotein2146% helix, 50% strand—
AAntibody DF2F-b.04 heavy chainprotein2156% helix, 52% strand—
CHIV fusion peptide residues (512-519)protein838% helix, 0% strand—

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14500.580.7458empty
2610.270.7320empty

Interfaces

3 interfaces between chains.

  • B–A · 1695 Ų buried · 17 hydrogen bonds · protein-protein
  • B–C · 367 Ų buried · 8 hydrogen bonds · protein-protein
  • A–C · 338 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 6P7H · Vaccine-elicited nhp fp-targeting neutralizing antibody DF2F-B.04 in complex with HIV… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.